- Jason Edward Ochs
- July 6, 2017
Wearables, the more frequently seen watch-like devices that now nearly 1 in 6 adults are wearing and fast becoming a hit across the United States. The wearable industry hit $2 billion in 2015, is expected to hit $3 billion in…
- Jason Edward Ochs
- June 28, 2017
Every Mother and Father’s worst nightmare: Junior trying to climb up his chest of drawers only to have it tip on him and crush him. The risk is real and it still happens. Parents cannot be more mindful when purchasing…
- Jason Edward Ochs
- June 14, 2017
My firm filed the first and only class action in Wyoming on behalf of Wyomignites who were duped into purchasing the Volkswagen vehicles that were later discovered to be outfitted with diesel emission devices that operated to circumvent smog testing….
- Jason Edward Ochs
- June 4, 2017
In a continued effort to bring to you updates in regards to what we have previously blogged could very well be a record-setting-year for Johnson & Johnson with respect to jury verdicts, we wanted to report the latest in our…
- Jason Edward Ochs
- May 28, 2017
While technology continues to outpace the law, new and emerging legal issues will arise in an effort to keep up with the oft changing landscape that technology has created in today’s society; not the least of which will be cyber…
- Jason Edward Ochs
- May 24, 2017
The Food and Drug Administration has issued a safety alert warning of the increased risk of pancreatitis in patients taking the irritable-bowel syndrome (IBS) drug Verbizi (eluxadoline). Verbizi is most often prescribed for IBS with diarrhea in both men and…
- Jason Edward Ochs
- May 19, 2017
The US Food and Drug Administration has issued a warning regarding the relatively new diabetes 2 drug most notably known as Invokana regarding leg and toe amputations. The warning states: Based on new data from two large clinical trials, the…
- Jason Edward Ochs
- May 11, 2017
The Food and Drug Administration has issued a recall alert for the Zimmer Biomet Reverse Shoulder that is surgically implanted to help restore arm movement. The recall is a Class I recall, which is the most urgent and serious type…
- Jason Edward Ochs
- May 9, 2017
A new study in the British Journal of Medicine has resurrected the debate and concern over cardiovascular risk linked to the commonly utilized pain relievers known as nonsteroidal anti-inflammatory drugs, or NSAIDs. The study involved a systematic review of studies…
- Jason Edward Ochs
- May 6, 2017
The U.S. Consumer Product Safety Commission (CPSC) has warned consumers to immediately stop using the LayZ Board self-balancing scooters (also known and sold as hoverboards). The warning follows a tragic house fire on March 10, 2017, in Harrisburg, PA, which…
